Jeffrey R Jasper

Title: The Innovations of Jeffrey R. Jasper

Introduction

Jeffrey R. Jasper is an accomplished inventor based in Mountain View, CA. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative therapeutic combinations. His work focuses on enhancing treatment options for patients in need.

Latest Patents

One of Jeffrey's notable patents is titled "Combinations of GLP-1R and THRβ agonists and methods of use thereof." This patent involves combinations that include a glucagon-like peptide-1 receptor (GLP-1R) agonist and a thyroid hormone receptor beta (THRβ) agonist. The methods described in the patent aim to provide effective treatment options for subjects requiring such combinations. Jeffrey holds 1 patent in this area.

Career Highlights

Jeffrey R. Jasper has established himself as a key figure in the pharmaceutical industry. He is currently associated with Terns Pharmaceuticals, Inc., where he continues to innovate and develop new therapeutic solutions. His expertise and dedication to research have positioned him as a valuable asset in his field.

Collaborations

Throughout his career, Jeffrey has collaborated with talented professionals, including Christopher T. Jones and Kevin P. Quinn. These partnerships have fostered a collaborative environment that enhances the development of innovative solutions in pharmaceuticals.

Conclusion

In summary, Jeffrey R. Jasper is a prominent inventor whose work in pharmaceutical innovations has the potential to significantly impact patient care. His contributions, particularly in the area of GLP-1R and THRβ agonist combinations, highlight his commitment to advancing medical science.